Ovizio logo — We bring automated cell-monitoring solutions for cell & gene...

Ovizio

We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications.

Founded 2010 Belgium Belgium 9 employees Grant Total: $8.05M AI, Biotechnology +3

General Information

Company Name Ovizio
Founded Year 2010
Location Belgium Belgium
Employees 9
Industries AI, Biotechnology, Life Sciences +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Ovizio. To contact Ovizio, visit ovizio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ovizio

Ovizio offers cutting-edge automated cell-monitoring solutions tailored for the cell & gene therapy, vaccine industry, and broader life sciences applications. Their unique technology, grounded in patented differential digital holography, enables easy-to-use, label-free, and non-invasive three-dimensional imaging of living cells.

The company's advanced systems can efficiently track cell density, morphology, viability, viral infection kinetics, and activation status, making them essential tools for both R&D and manufacturing settings. In addition to improving quality, Ovizio's microscopes offer potential for significant cost reduction across applications.

Founded in 2010 and headquartered in Belgium, Ovizio operates at the intersection of AI, Biotechnology, Life Sciences, Medical Devices, and VR/AR. Their most recent financial boost came as a €50.00K grant from EASME - EU Executive Agency for SMEs in 2017.

Taxonomy: Automated Cell-Monitoring, Cell & Gene Therapy, Vaccine Industry, Life Sciences Applications, Holographic Imaging, Real-Time Imaging, Digital Holographic Microscopy, Cell Culture Monitoring, Bioprocessing, 4D Microscopy, Morphology Analysis, Viral Infection Kinetics, Cell Viability Tracking, Machine Learning Software, Flow Cytometry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Jan 2017
Venture Round €8.00M 5
New Science Ventures, QBIC +3
16 Nov 2015

Ovizio Alternatives & Competitors

Ovizio vs

Deeper insights, better treatments - a single cell at a time

Corporate Round
51 employees
Biotechnology, Health and Wellness
Ovizio vs

We build high tech equipment supporting end-to-end development and manufacture of cell and gene ther...

Debt Financing
69 employees
Biotechnology, Life Sciences
Ovizio vs
EnGeneIC
EnGeneIC Australia

First-in-class cyto-immunotherapy platform targeting the tumour directly and leveraging the patient'...

Venture round
55 employees
Biotechnology, Health and Wellness

FAQ About Ovizio

We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications.
Ovizio was founded in 2010.
Ovizio is headquartered in Belgium.
Ovizio operates in AI, Biotechnology, Life Sciences, Medical Devices and VR/AR. Its work centres on Automated Cell-Monitoring, Cell & Gene Therapy, Vaccine Industry and Life Sciences Applications.
Ovizio has approximately 9 employees.
Ovizio has completed 2 funding rounds, raising a total of $8.05M. The latest funding stage is Grant.
Top alternatives and competitors to Ovizio include ThinkCyte, Astraveus, EnGeneIC, Great Bay Bio 大湾生物, Rhizocore Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ovizio and ThinkCyte are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ovizio, https://bouncewatch.com/company/ovizio, updated 6 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes